SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biogen Pharmachem - Quaterly Results

08 Nov 2025 Evaluate
Revenue showed a marginal decline at Rs. 0.00 millions. For the quarter ended September 2025, as compared to corresponding quarter of last year.The Net Loss for the quarter ended September 2025 is Rs. -4.91 millions as compared to Net Loss of Rs. -9.96 millions of corresponding quarter ended September 2024 Operating profit Margin for the quarter ended September 2025 improved to -4.91% as compared to -9.96% of corresponding quarter ended September 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 0.00 0.00 0.00 15.43 -0.91 -1795.60 8.38 23.82 -64.82
Other Income -1.05 -6.50 -83.85 -1.05 -6.50 -83.85 0.00 0.00 0.00
PBIDT -4.91 -9.96 -50.70 8.54 -11.55 -173.94 -2.93 19.31 -115.17
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -4.91 -9.96 -50.70 8.54 -11.55 -173.94 -2.93 19.31 -115.17
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT -4.91 -9.96 -50.70 8.54 -11.55 -173.94 -2.93 19.31 -115.17
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -4.91 -9.96 -50.70 8.54 -11.55 -173.94 -2.93 19.31 -115.17
Equity 902.60 652.60 38.31 902.60 652.60 38.31 652.60 652.60 0.00
PBIDTM(%) 0.00 0.00 0.00 55.35 1269.23 -95.64 -34.96 81.07 -143.13

Biogen Pharmachem Share Price

0.46 -0.01 (-2.13%)
05-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 218.65
Adani Enterprises 2463.55
Amrapali Industries 17.95
Rashi Peripheral 501.50
PDS 277.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×